Pure Global

Cancer-related multiple gene mutation/mRNA expression IVD, kit, nucleic acid technique (NAT) - UK MHRA Medical Device Registration

Cancer-related multiple gene mutation/mRNA expression IVD, kit, nucleic acid technique (NAT) is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 113736. The device is manufactured by Myriad International GmbH from Germany, classified as In Vitro Diagnostic Device. The authorized representative in the UK is Myriad Genetics Ltd.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, authorized representative details, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
MHRA Registered
In Vitro Diagnostic Device
๐Ÿ‡ฌ๐Ÿ‡ง
Cancer-related multiple gene mutation/mRNA expression IVD, kit, nucleic acid technique (NAT)
MHRA Device ID: 113736โ€ขRef: 113736

Device Type

In Vitro Diagnostic Device

Devices

Cancer-related multiple gene mutation/mRNA expression IVD, kit, nucleic acid technique (NAT)

Type

IVD General

Date Registered

Nov 18, 2021

Last Updated

Oct 26, 2022

Manufacturer Information

Address

Nattermannallee 1

Kรถln, Germany

Created Date

Nov 18, 2021

Authorized Representative

Relationship Type

UK Responsible Person

Address

The Stanley Building, 7 Pancras Square

London, England, United Kingdom

Postcode: N1C 4AG

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing